Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypsin-like serine proteases are a family of enzymes that cleave peptide bonds after lysine or arginine residues. The Ser190 site refers to proteases within this family that have a serine residue at position 190 in their S1 binding pocket. This structural difference allows for the design of selective inhibitors, particularly halo-substituted amidines which show up to 220-fold selectivity for Ser190 over Ala190 enzymes. These proteases are involved in diverse biological processes including digestion, blood coagulation, immune responses, and are implicated in diseases such as thrombosis and cancer, making them important drug targets.
Inhibition of serine protease activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypsin-like Serine Protease (Ser190 site).